Is a complete TPEX/4162 research report available?

No complete published report is available for tpex/4162 (TPEX/4162) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/4162 stock profile: metrics, valuation and analysis

Market cap	7.8B
Revenue (ttm)	1B
Net income (ttm)	538.8M
EPS (ttm)	NT$3.75
Shares out	143.7M
P/E (trailing)	14.4x
Dividend	NT$2.00 (3.46%)
Volume	491,861
Beta	0.14

All TPEX/4162 indicators

Market & fundamental data

Available fields

253

Groups with data

Currency

TWD

Showing 253 of 253 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	45
Employees Change	1%
Employees Change Percent	2.27
Enterprise value	TWD 2.7B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	32.85
Isin	TW0004162003
Last refreshed	2026-09-12
Market cap	TWD 7.8B
Price	TWD 54
Price currency	TWD
Rev Per Employee	22,779,066.67x
Sector	Healthcare
Sector PE	87.76
Sector PE Fwd	27.81
Sic	2836
Symbol	tpex/4162
Website	https://www.pharmaengine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.94%
EV Earnings	5.06x
EV/EBIT	5.62x
EV/EBITDA	5.5x
EV/FCF	5.04x
EV/Sales	2.66x
FCF yield	6.96%
P/B ratio	1.58x
P/E ratio	14.4x
P/S ratio	7.57x
PE Ratio10 Y	71.72x
PE Ratio3 Y	26.12x
PE Ratio5 Y	30.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.32%
EBITDA Margin	47.49%
FCF margin	52.71%
Gross margin	93.87%
Gross Profit	TWD 962.2M
Gross Profit Growth	-60.45%
Gross Profit Growth Q	28.55%
Gross Profit Growth3 Y	17.33%
Gross Profit Growth5 Y	-2.95%
Net Income	TWD 538.8M
Net Income Growth	-66.96%
Net Income Growth Q	653.64%
Net Income Growth Qo Q	-2.32%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	21.88%
Net Income Growth5 Y	-7.19%
Pretax Margin	63.07%
Profit Margin	52.56%
Profit Per Employee	TWD 12M
Profitable Quarters	TWD 26
Profitable Years	12
ROA	5.44
Roa5y	9.06
ROCE	9.81
ROE	11.26
Roe5y	14.26
ROIC	21,214.8
Roic5y	102.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.29%
Cagr15y	2.9%
Cagr1y	-15.87%
Cagr3y	-9.84%
Cagr5y	2.83%
Div CAGR10	1.84%
Div CAGR3	0%
Div CAGR5	-4.63%
EPS Growth	-66.9
EPS Growth Q	675
EPS Growth Qo Q	-2.11
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	21.9
EPS Growth5 Y	-6.93
FCF Growth	-69.02%
FCF Growth Qo Q	-62.17%
FCF Growth3 Y	24%
FCF Growth5 Y	-8.27%
OCF Growth	-69%
OCF Growth Qo Q	-62.09%
OCF Growth10 Y	0.2%
OCF Growth3 Y	23.58%
OCF Growth5 Y	-8.26%
Revenue Growth	-58.69x
Revenue Growth Q	31.11x
Revenue Growth Qo Q	7.6x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	16.53x
Revenue Growth5 Y	-2.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.18
Assets	TWD 5.4B
Cash	TWD 5.1B
Current Assets	TWD 5.4B
Current Liabilities	TWD 478.9M
Debt	TWD 37.8M
Debt EBITDA	TWD 0.08
Debt Equity	TWD 0.01
Debt FCF	TWD 0.07
Equity	TWD 4.9B
Interest Coverage	980
Liabilities	TWD 512.3M
Long Term Assets	TWD 56.1M
Long Term Liabilities	TWD 33.4M
Net Cash	TWD 5B
Net Cash By Market Cap	TWD 64.88
Net Cash Growth	-6.73%
Net Debt EBITDA	TWD -10.34
Net Debt Equity	TWD -1.03
Net Debt FCF	TWD -9.32
Tangible Book Value	TWD 4.9B
Tangible Book Value Per Share	TWD 34.17
WACC	4.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.2
Inventory Turnover	1.71
Net Working Capital	TWD -176M
Quick ratio	11.11
Working Capital	TWD 4.9B
Working Capital Turnover	TWD 0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.05%
Dividend Growth	-66.67%
Dividend Growth Years	1%
Dividend per share	TWD 2
Dividend Years	12
Dividend Yield	3.46%
Ex Div Date	2026-08-17
Last Dividend	TWD 2
Payout Frequency	Annual
Payout Ratio	159.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-62.28%
1Y total return	-15.86%
200-day SMA	62.75
3Y total return	-26.71%
50-day SMA	62
50-day SMA vs 200-day SMA	50under200
5Y total return	14.95%
All Time High	246.6
All Time High Change	-77.77%
All Time High Date	2014-05-28
All Time Low	33.1
All Time Low Change	65.56%
All Time Low Date	2020-03-23
ATR	1.38
Beta	0.14
Beta1y	0.17
Beta2y	0.32
Ch YTD	-22.16
High	54.7
High52	74.4
High52 Date	2025-12-08
High52ch	-27.42%
Low	53.9
Low52	53
Low52 Date	2026-05-28
Low52ch	1.89%
Ma50ch	-11.61%
Price vs 200-day SMA	-12.67%
RSI	27.7
RSI Monthly	35.69
RSI Weekly	38.41
Sharpe ratio	-0.67x
Sharpe Ratio3y	-0.19x
Sharpe Ratio5y	0.14x
Sortino ratio	-0.76
Sortino Ratio3y	-0.12
Sortino Ratio5y	0.36
Total Return	3.51%
Tr YTD	-19.57
Tr15y	53.62%
Tr1m	-11.11%
Tr1w	-5.19%
Tr3m	-0.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93,450,822%
Net Borrowing	-8,685,000
Shares Insiders	1.23%
Shares Institutions	5.8%
Shares Out	143,677,640
Shares Qo Q	-0.09%
Shares Yo Y	-0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 540.3M
Adjusted OCF	540,605,000
Average Volume	263,967.55x
Bv Per Share	34.17
CAPEX	TWD -339,000
Ch10y	-71.41
Ch15y	12.72
Ch1m	-13.97
Ch1w	-5.19
Ch1y	-18.57
Ch3m	-3.86
Ch3y	-35.68
Ch5y	-8.67
Ch6m	-4.86
Change	-1.46%
Change From Open	-0.55
Close	54.8
Days Gap	-0.91
Depreciation Amortization	1,732,000
Dollar Volume	26,560,494
Earnings Date	2026-11-06
EBIT	TWD 485.1M
EBITDA	TWD 486.8M
EPS	TWD 3.75
F Score	5
FCF	TWD 540.3M
FCF EV Yield	19.83x
FCF Per Share	TWD 3.76
Financing CF	-870,609,000
Fiscal Year End	December
Founded	2,002
Graham Number	53.69275
Graham Upside	-0.57
Income Tax	TWD 107.7M
Investing CF	-1,263,396,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2026-06-30
Last Split Date	2017-07-26
Last Split Type	Forward
Lynch Fair Value	TWD 18.75
Lynch Upside	-65.28
Ma150	59.78
Ma150ch	-8.33%
Ma20	58.56
Ma20ch	-6.42%
Net CF	-1,593,352,000
Next Earnings Date	2026-11-06
Open	54.3
P FCF Ratio	14.36
P FCF Ratio SBC	14.36
P OCF Ratio	14.35
P OCF Ratio SBC	14.35
Payment Date	2026-09-04
Position In Range	12.5
Ppne	39,726,000
Price Date	2026-09-11
Price EBITDA	TWD 15.94
Ptbv Ratio	1.58
Relative Volume	1.86x
Revenue	1,025,058,000x
SBC By Revenue	0x
Share Based Comp	48,000
Tax By Revenue	10.51x
Tax Rate	16.66%
Tr6m	-1.7%
Volume	491,861
Z Score	13.18

TPEX/4162 (TPEX/4162)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/4162

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/4162 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/4162

Frequently asked questions